IDEAYA Biosciences (IDYA) Other Non-Current Liabilities (2018 - 2021)

IDEAYA Biosciences has disclosed Other Non-Current Liabilities across 4 years of filings, most recently posting $6000.0 for Q3 2021.

• Other Non-Current Liabilities for Q3 2021 came in at $6000.0, down 50.0% year-over-year; the trailing twelve-month figure through Sep 2021 was $6000.0 (down 50.0% YoY), and the FY2020 annual result was $12000.0, down 64.71% from the prior year.
• Other Non-Current Liabilities came in at $6000.0 for Q3 2021 at IDEAYA Biosciences, roughly flat from $6000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $113000.0 in Q4 2018 to a low of $6000.0 in Q1 2021.
• The 4-year median for Other Non-Current Liabilities is $16000.0 (2020), against an average of $30727.3.
• Across the five-year window, Other Non-Current Liabilities sank 76.92% in 2020 and plunged 50.0% in 2021, its largest moves.
• IDEAYA Biosciences' Other Non-Current Liabilities stood at $113000.0 in 2018, then tumbled by 69.91% to $34000.0 in 2019, then plunged by 64.71% to $12000.0 in 2020, then slumped by 50.0% to $6000.0 in 2021.
• The last three Other Non-Current Liabilities figures came in at $6000.0 (Q3 2021), $6000.0 (Q2 2021), and $6000.0 (Q1 2021), per Business Quant data.